Cleo Diagnostics company info

What does Cleo Diagnostics do?
Cleo Diagnostics (ASX:COV) is a Melbourne-based medical technology company developing a blood test for early-stage ovarian cancer detection. Their goal is to improve diagnosis accuracy and potentially reduce unnecessary surgeries. The blood test leverages a patented biomarker and aims to be compatible with existing lab equipment for easy adoption.
Cleo Diagnostics company media
Company Snapshot

Is Cleo Diagnostics a public or private company?

key
Ownership
Public

How many people does Cleo Diagnostics employ?

people
Employees
4

What sector is Cleo Diagnostics in?

pie chart
Sector
Healthcare

Where is the head office for Cleo Diagnostics?

location pin
Head Office
Melbourne, Australia

What year was Cleo Diagnostics founded?

founded flag
Year Founded
2021
What does Cleo Diagnostics specialise in?
/Diagnostic Technology /Cancer Detection /Cervical Screening /Biomedical Research /Healthcare Innovations /Clinical Trials

What are the products and/or services of Cleo Diagnostics?

Overview of Cleo Diagnostics offerings
Triage Test: This is their lead product, designed to identify women with a high likelihood of malignant ovarian tumors before surgery.
Recurrence Test: This test is planned to help monitor patients post-treatment and detect potential cancer recurrence early.
Screening Test: This future test aims for broader screening of women in the general population for ovarian cancer.

Who is in the executive team of Cleo Diagnostics?

Cleo Diagnostics leadership team
  • Dr. Richard  Allman Ph.D.
    Dr. Richard Allman Ph.D.
    CEO & Exec. Director
  • Dr. Andrew N. Stephens
    Dr. Andrew N. Stephens
    Chief Scientific Officer & Exec. Director
  • Prof. Thomas William Jobling
    Prof. Thomas William Jobling
    Lead Medical Advisor & Independent Non-Exec. Director
  • Ms. Pauline M. Moffatt AAICD, B.Com., BCom, FGIA
    Ms. Pauline M. Moffatt AAICD, B.Com., BCom, FGIA
    Company Sec.